Skip to main content

Table 4 The mRNA expression of BMP2, MMP8, and MMP9 in monocyte-derived (M2-like) macrophages from AS patients and healthy controls before and after CGS-21,680 treatment

From: A2A adenosine receptor agonist reduced MMP8 expression in healthy M2-like macrophages but not in macrophages from ankylosing spondylitis patientsAuthors and affiliations

 

Relative gene expression

Healthy macrophages

Treated healthy macrophages

Mean fold changes (95% CI)

P -value

BMP2

0.19 ± 0.07

0.19 ± 0.10

0.99 (0.77, 1.26)

0.974

MMP8

0.11 ± 0.09

0.03 ± 0.01

0.26 (0.19, 0.36)

0.002

MMP9

4333.5 ± 2247.9

5556.2 ± 3580.8

1.28 (0.98, 1.68)

0.101

 

AS macrophages

Treated AS macrophages

Mean fold changes (95% CI)

P -value

BMP2

0.09 ± 0.05

0.15 ± 0.11

1.62 (0.96, 2.72)

0.167

MMP8

0.07 ± 0.09

0.05 ± 0.08

0.78 (0.45, 1.34)

0.122

MMP9

4860.4 ± 1943.2

4696.05 ± 1372.1

0.97 (0.84, 1.11)

0.729

  1. BMP: Bone morphogenetic protein; MMP: Matrix metalloproteinase